Amir Mian, M.D., M.S.
Assistant Professor of Pediatrics
Phone: 501-364-1494

Research Overview

Dr. Mian's translational research interest includes exploring cytokines and proteins to predict clinical outcomes for patients receive chemotherapy. He focuses on discovery and application of novel cytokine based biomarkers as predictors of outcomes. In 2008, Dr. Mian received a CUMG grant to study a risk-stratified predictive model based on mediators of inflammation. Most recently, Dr. Mian was named "Hyundai Scholar" 2011-2012 and received "Hope on Wheels" grant to study correlation of various proteins with clinical outcome during fever neutropenia.  

Key Publications

• Standardized order set used in ED improves time to first dose of antibiotics for patients with fever-neutropenia. Thomas Cash MD, James Grahm MD, Amir Mian MD, MS. In press. Pediatric Emergency Care. 2013
• Multidisciplinary Approach to Reduction of Central Line Associated Blood Stream Infections (CLABSI): An Institutional Experience with Collaborative Guidelines. Amir Mian MD, MS, Crystal Russell RN, Michele Honeycutt RN, Carol Oldridge RN. The Journal of the Arkansas Medical Society. 2012;109(7):128-131
• Biomarkers for risk stratification of febrile neutropenia among children with malignancy: A pilot study. Amir Mian, MD, MS, David Becton MD, Robert Saylors MD, Laura James MD, Xinyu Tang PhD, Adnan Bhutta MD, Parthak Pradham MD. Pediatric Blood and Cancer 2012 Aug;59(2):238-45.
• Aspergillus infection and extracorporeal membrane oxygenation support. Garcia X, Mian  A, Mendiratta P, Gupta P, Rycus P, Prodhan P. Journal of Intensive care Medicine 2012.
• Moya Moya syndrome in a patient with sickle cell disease. Index of Suspicion. A case report. Kevin Bielamowicz, MD, Amir Mian, MD, MS. Pediatrics in Review. Pediatrics in Review. 2011; 32:389-396 
• Myeloid Sarcoma. A case report and review of literature. Kevin Bielamowicz, MD, David Becton, MD, Amir Mian, MD, MS. Journal of Pediatric Hematology Oncology 2011. 33(7):330-332. 
• Antibiotic Hypersensitivity Reactions in cystic fibrosis. Piperacillin induced life-threatening hemolytic anemia in a pediatric patient. Alma Chavez MD, Amy Scurlock MD, Amir Mian MD, Gulnur Com MD. Journal of Cystic Fibrosis 2010.8:10-16   
• Thrombocytopenia in a 3 year old well appearing child. Kevin Bielamowicz, MD, Amir Mian, MD, MS. Clinical Pediatrics 2011. 50(8):777-78 
• More Than Meets the Eye—A Presentation of Extramedullary Infiltration. A Brief report. Shelly Baldwin MD, Amir Mian MD, MS. Clinical Pediatrics 2010. 49(10):986-988
• A Child with Possible Malignancy: An Approach for Primary Care Physicians. Amir Mian, MD, MS. Journal of Arkansas Medical Society. 2010;106(11):267-268  
• Hemophagocytic lymphohistiocytosis secondary to Ehrlichia chaffeensis infection. A case report. Samuel Burns MD, Robert Saylors MD, Amir Mian MD, MS. Journal of Pediatric Hematology Oncology. 2010;32(4):142-143
• Index of Suspicion: Case Report. Amir Mian MD, David Becton MD, Douglas Blackall MD. Pediatric in Review. April 2009; 30:139-145. 
• Genotype–phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations. A Trizzino, U Stadt, I Ueda, K Risma, G Janka, E Ishii, K Beutel, J Sumegi, S Cannella, D Pende, A Mian, J-I Henter, G Griffiths, A Santoro, A Filipovich, M Aricò. Journal of Medical Genetics. 2008;45:15-21.
• “Clinical Predictors of Optic Pathway Glioma in NF-1 patients”. Published. University of Cincinnati, School of Medicine, Cincinnati, Ohio (47 pages) Ohio Link February 2006. Amir Mian MD, MS, Ranajit Chakraborty PhD, Bandana Chakraborty DSc, John Perentesis MD

To find additional publications by Amir Mian, please visit Pubmed Central, a National Institutes of Health-operated site for electronic distribution of life sciences research reports.

Research Funding

Hyundai Scholar. Hope-on-Wheels Grant. 2011-2012
ACHRI CUMG Grant. 2008-2010